Subject
Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. Vital statistics in japan, tabulated by cancer information service, national cancer center, japan. Available online: https://ganjoho.Jp/reg_stat/statistics/data/dl/en.Html. Accessed nov 2, 2021. .
2. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (espac-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017
3. Adjuvant chemotherapy of s-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (jaspac 01);Uesaka;Lancet,2016
4. Folfirinox or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018
5. Folfirinox versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献